The EPS projection of Evolent Health Inc (NYSE:EVH) for period quarter completed 2016-12-31 is $-0.14.
The EPS estimates pronounced a week and 30 days ago were $-0.14 and $-0.14 correspondingly. The EPS forecasts specified 60 and 90 days before were $-0.14 and $-0.14 respectively. From a week ago, the aberration in EPS forecast is -0.03 percent.
The mean EPS prediction straightaway before the earnings release for the quarter completed 2 is $-0.14 based on 7 EPS estimations. The EPS stated on 2016-08-04 was $-0.25. The EPS surprise was $-0.09, or -56.25 percent. The standard deviation as per known EPS estimates was $0.01.
The positive EPS revisions were 0 a week earlier and negative revisions were 1. In last 30 and 60 days, the positive EPS revisions were 0 and 1 correspondingly, while for 90 and 120 days, revisions count was 4 and 4.
The negative revisions of per-share earnings in the last 30 and 60-days were 1 and 1 in that order. however, for 90 and 120 days’ period, the count was 1 and 1 in that order.
EPS revisions upgrade and downgrade in the last 18 days were 1 and 2 correspondingly.
Quarterly Sales Estimates
The arithmetic mean of probable annual sales of Evolent Health Inc (NYSE:EVH) is $63.337 and the median was $60.7. The estimate is stated by 7 analysts for the fiscal 2016.
The highest annual projection is $80.6 and lowest sales target is $59.1. This marks a standard deviation of $7.638.
Almost 7 have given revised positive sales forecast in the past week and 7 have downgraded forecasts. As per the stated estimates, the change in target from the past week is 4.874 percent.
Nearly 7 have revised sales projections in positive side over the past month and 7 have downgraded forecasts. This shows a mean estimate deviation of 4.874 percent.
Just about 7 have revised sales forecast on plus side over the quarter and 7 have downgraded forecasts. This shows mean estimate deviation of 5.501 percent.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...